Ryo Teramachi

Ryo Teramachi

Auto-generated profile, based on publicly available information

Ryo Teramachi

Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan; Department of Emergency and Intensive Care Medicine, Intensive Care Unit, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2025 in Annals of the American Thoracic Society
Verified
Journal Article
Closed access
RTRyo Teramachi
Ryo Teramachi
TFTaiki Furukawa
Taiki Furukawa
YKYasuhiro Kondoh
Yasuhiro Kondoh
MKMasayuki Karasuyama
Masayuki Karasuyama
HHHironao Hozumi
Hironao Hozumi
MIMAKOTO ISHII
MAKOTO ISHII
Rationale: Some patients with interstitial lung disease (ILD) have a high mortality rate or experience acute exacerbation of ILD (AE-ILD) that results in increased mortality. Early identification of these high-risk patients and accurate prediction of the onset of these important events is important to determine treatment strategies. Although various factors that affect disease behavior among patients with ILD hinder the accurate prediction of these events, the use of longitudinal information may enable better prediction. Objectives: To develop a deep learning (DL) model to predict composite outcomes defined as the first occurrence of AE-ILD and mortality using longitudinal data. Methods: Longitudinal clinical and environmental data were retrospectively collected from consecutive patients with ILD at two specialty centers between January 2008 and December 2015. A DL model was developed to predict composite outcomes using longitudinal data from 80% of patients from the first center, which was then validated using data from the remaining 20% of patients and the second center. The developed model was compared with the univariate Cox proportional hazard (CPH) model using the ILD gender-age-physiology (ILD-GAP) score and multivariate CPH model at the time of ILD diagnosis. Results: AE-ILD was reported in 218 patients among the 1,175 patients enrolled, whereas 380 died without developing AE-ILD. The truncated concordance index (C-index) values of univariate/multivariate CPH models for composite outcomes within 12, 24, and 36 months after prediction were 0.789/0.843, 0.788/0.853, and 0.787/0.853 in internal validation, and 0.650/0.718, 0.652/0.756, and 0.640/0.756 in external validation, respectively. At 12 months after ILD diagnosis, the DL model outperformed the univariate CPH model and multivariate CPH model for composite outcomes within 12 months, with concordance index values of 0.842, 0.840, and 0.839 in internal validation, and 0.803, 0.744, and 0.746 in external validation, respectively. Neutrophils, C-reactive protein, ILD-GAP score, and exposure to suspended particulate matter were strongly associated with the composite outcomes. Conclusions: The DL model can accurately predict the incidence of AE-ILD or mortality using longitudinal data.

25 May 2026 in Respiratory Investigation
Verified
Journal Article
Closed access
RTRyo Teramachi
Ryo Teramachi
JFJun Fukihara
Jun Fukihara
SISeiya Ichihara
Seiya Ichihara
KKKensuke Kataoka
Kensuke Kataoka
RTReoto Takei
Reoto Takei
YKYasuhiro Kondoh
Yasuhiro Kondoh

25 March 2026 in Respiratory Investigation
Verified
Journal Article
Closed access
TYToshiki Yokoyama
Toshiki Yokoyama
RTRyo Teramachi
Ryo Teramachi
KHKaho Hiramitsu
Kaho Hiramitsu
SHSatoshi Hagimoto
Satoshi Hagimoto
RTReoto Takei
Reoto Takei
YKYasuhiro Kondoh
Yasuhiro Kondoh

15 May 2026 in Respiratory Investigation
Verified
Journal Article
Closed access
YMYuta Mori
Yuta Mori
TMToshiaki Matsuda
Toshiaki Matsuda
ASAtsushi Suzuki
Atsushi Suzuki
SHSatoshi Hagimoto
Satoshi Hagimoto
RTReoto Takei
Reoto Takei
YKYasuhiro Kondoh
Yasuhiro Kondoh